Medicamenteuze behandeling covid-19 in de tweede lijn
Files
Publication date
2022-07-21
Authors
Hensgens, Marjolein
Gieling, Emilie M.
de Lange, Dylan W
Boersma, Wim G
van der Linden, Paul
Sinha, Bhanu N M
de Boer, Mark
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
In this article we provide an overview of the current treatment recommendations for COVID-19. These recommendations are made by the SWAB (StichtingWerkgroepAntibioticabeleid), in cooperation with the FMS (FederatieMedischSpecialisten (online: swab.nl/nl/covid-19.). Treatment options for patients in both ambulatory care and admitted to the hospital are listed. These treatment options include both antiinflammatory and antiviral therapy.
Keywords
COVID-19, Hospitalization, Humans, Inpatients, SARS-CoV-2, Taverne, General Medicine, English Abstract, Journal Article
Citation
Hensgens, M P M, Gieling, E, de Lange, D, Boersma, W G, van der Linden, P, Sinha, B N M & de Boer, M 2022, 'Medicamenteuze behandeling covid-19 in de tweede lijn', Nederlands Tijdschrift voor Geneeskunde, vol. 2022, no. 166, D6857, pp. 1-6. < https://www.ntvg.nl/artikelen/medicamenteuze-behandeling-covid-19-de-tweede-lijn >